The difference in circulating PT IgG levels in aP-primed childbearing-age women and their offspring is a paramount finding, as lower availability of PT antibody might compromise protection in the mother-infant dyad, with the infant being more susceptible and at higher risk of infection. The gene discussed is F2; the disease is infection.